Allergy Testing & Treatment: The Complete Clinical Guide

Written by Empire Medical Training Editorial Team

Medically reviewed by Sherry Wehner, MD Board-Certified Pathologist & Dermatopathologist; Aesthetic & Wellness Medicine

Updated June 2026 ·10 min read

Allergy testing and treatment sits at the intersection of immunology, primary care, dermatology, and practice economics. Allergy is, as Dr. Sherry Wehner frames it in Empire's course, simply a hypersensitivity reaction that occurs when a patient is exposed to an antigen they are sensitive to — yet that one mechanism drives a remarkable range of everyday complaints, from a runny nose to anaphylaxis. This guide is the hub for our allergy cluster: read it for the full landscape, then go deeper through the individual guides linked throughout and in the directory below.

Because allergy care is a Your-Money-or-Your-Life medical topic with real safety stakes, accuracy comes first. Throughout this guide we draw a hard line between a true IgE-mediated allergy and a non-allergic intolerance, we say plainly which tests are validated and which are not, and we flag the patients who belong with a board-certified immunologist rather than in a general practice. Nothing here is medical advice; it is clinical education for providers and an orientation for patients deciding whether to ask their physician about allergy testing.

The background of allergic disease

Allergy is far more common than most clinicians appreciate at the point of care. Allergic conditions affect more than 56 million Americans. Roughly 30% of American adults have environmental allergies, and at least 10% have at least one food allergy. Taken together, allergy is the sixth leading cause of chronic disease in the United States — a population large enough to fill an entire service line that most practices currently refer away.

Like almost all disease, allergy is multifactorial, depending on genetics, environment, and immunology. Genetics weigh heavily: a child with one allergic parent is roughly 30–50% more likely to develop allergies, and with two allergic parents that rises to about 60–80%. Environment then determines which allergens a given patient actually reacts to, and the immunology — the IgE-mast cell axis — determines how that reaction is expressed.

That immunology is worth understanding because it explains both the symptoms and the treatment. When an antigen binds IgE on a mast cell, the cell degranulates and releases mediators — the most important being histamine. Histamine drives nerve stimulation (itching), vasodilation (the redness or flare), and endothelial gapping that lets fluid leak into tissue (the swelling, or wheal). The deeper mechanics of this cascade are covered in histamine and the allergic response, and the full constellation of presentations in allergy symptoms.

The major allergens and the conditions they drive

The allergens clinicians encounter most are predictable. On skin-prick testing, the common culprits are cat, dog, grasses, house dust mites, peanuts, trees, molds, eggs, and milk. These divide loosely into environmental (inhalant) allergens, which drive the chronic respiratory and ocular conditions, and food allergens, which drive immediate reactions. A full breakdown lives in types of allergens and environmental allergies.

The same handful of allergens produce a recognizable set of conditions, all of them mediated by the histamine response above:

• Allergic rhinitis — the classic runny, congested, sneezing nose; the most common allergic presentation. See allergic rhinitis.
• Allergic conjunctivitis — itchy, watery, red eyes, often paired with rhinitis.
• Sinusitis — chronic or recurrent sinus inflammation downstream of allergic congestion.
• Eczema (atopic dermatitis) — an allergic skin condition that overlaps with, but is distinct from, contact dermatitis. See eczema and allergies.
• Asthma — allergic airway disease, and a condition serious enough to demand proper medical management in its own right. See asthma and allergies.

Contact dermatitis deserves a separate note: it is T-cell mediated rather than the IgE-mast cell response behind the conditions above, with the most common triggers being metals and jewelry, cosmetics, preservatives, and detergents. That difference is why it is evaluated by patch testing rather than prick testing — a distinction we return to under skin testing.

How allergy is tested

There are two broad pillars of allergy testing — skin testing and blood testing — plus a set of specialized tests. None of them stands alone: as Wehner stresses, a result is only meaningful when interpreted against the patient's clinical history, and the goal is to confirm a suspected allergen, not to fish.

Skin testing comes in three forms. The skin-prick test introduces a small amount of allergen into the superficial skin and is the workhorse of allergy practice because it is cheap, quick, and gives visible results within minutes; a reaction is read as positive when the wheal is at least 3 mm larger in diameter than the negative control. The intradermal test injects allergen more deeply — more sensitive but less specific, with more false positives, and uncommon in U.S. human practice. Patch testing is the tool for contact dermatitis, applying antigens under occlusion for 48 hours. Read more in skin testing for allergies.

Blood testing measures specific IgE antibodies (historically the RAST test). It can screen many more antigens than a skin-prick panel and is especially valuable when skin testing is not possible — in patients who cannot stop antihistamines, who have severe eczema or dermatographism, who have a history of anaphylaxis, or in children under two. The trade-off is lower specificity, with its own false positives and false negatives. Full detail is in blood testing for allergies, and the more experimental assays — leukocyte histamine release and similar — in specialized allergy testing.

Food allergy vs food sensitivity — honestly

This is where careful language matters most, because the terms are routinely conflated and the testing market is full of products that are not validated. A true food allergy is a type 1, IgE-mediated reaction — it can produce immediate symptoms and, at its most severe, anaphylaxis, which is a medical emergency treated first-line with intramuscular epinephrine. It is diagnosed by clinical history together with skin-prick and/or specific-IgE testing, and confirmed where appropriate by a supervised oral food challenge.

A food sensitivity or intolerance is a different thing. The delayed reactions patients describe are often type 3, IgG-mediated, presenting hours to days later with vaguer symptoms such as fatigue, headache, or joint pain — but here the evidence base demands candor. IgG food “sensitivity” panels are not validated to diagnose food allergy and are not recommended by major allergy bodies such as the AAAAI and EAACI. They should not be presented to a patient as allergy diagnosis. The practical, validated tool for suspected intolerance is a structured elimination-and-reintroduction diet — removing one food for about two weeks at a time and observing symptoms, a process that is tedious but genuinely informative.

This is also the natural bridge to the rest of the functional-medicine picture. Suspected non-IgE food reactions overlap with gut and immune health, which is why this topic connects to food sensitivities and elimination diets and the gut health cluster. The full comparison — with a side-by-side table — is in food allergies vs food sensitivities.

Treatment: symptom management and immunotherapy

Allergy treatment runs on two tracks. The first is symptom management — antihistamines, intranasal and inhaled corticosteroids, and avoidance of identified triggers. These control symptoms but do not change the underlying sensitization, and they have a practical catch in a testing practice: antihistamines, tricyclic antidepressants, and topical steroids can blunt skin-test reactivity, so they have to be accounted for before testing.

The second track is the only one that changes the disease itself: immunotherapy. As Wehner puts it, allergy shots are not a cure, but they are desensitizing — they greatly decrease symptoms and improve quality of life, and they are the only disease-modifying allergy treatment. Two forms exist:

• Subcutaneous immunotherapy (SCIT) — conventional “allergy shots,” given in a build-up phase (one to three visits per week) and a maintenance phase (roughly every two to four weeks). Patients are observed about 30 minutes after each injection to catch any systemic reaction. SCIT is well-established and is usually covered by insurance when the patient has three or more positive environmental skin-prick results. See allergy immunotherapy.
• Sublingual immunotherapy (SLIT) — drops or tablets taken at home, more convenient but generally less effective; FDA-approved SLIT tablets exist for specific allergens (grass, ragweed, dust mite), while compounded sublingual drops are largely off-label and not typically covered by insurance. See sublingual immunotherapy.

Immunotherapy is also remarkably safe in practice — severe reactions are rare — but “rare” is not “never,” which is exactly why the 30-minute observation window and emergency readiness are non-negotiable. The exact dosing, escalation schedules, and vial preparation that make immunotherapy work are taught hands-on in Empire's course rather than reproduced here.

The practice opportunity: the in-office allergy lab

Here is the part that makes allergy compelling as a service line. The same 56 million-patient population that makes allergy a public-health problem makes it a practice opportunity — one Wehner built into her own clinic. Most general and aesthetic practices already see allergic patients every day and simply refer them out. Bringing testing and immunotherapy in-office keeps that care, and its revenue, in the practice while genuinely improving patients' lives.

An in-office allergy lab is the operational center of that service: the testing setup, the immunotherapy vials and their prescriptions, the observation protocol, and the recall workflow that brings patients back for maintenance and re-testing. Re-testing matters clinically too — after a course of immunotherapy you re-test to see how the patient has improved and, if needed, order a new prescription of vials. The build-out is covered in setting up an allergy lab, and the broader business case in how to add allergy testing to your practice.

On billing and coding: much of allergy testing and immunotherapy is reimbursable, and SCIT in particular is typically covered when the patient has three or more positive environmental results — which is what makes this a defensible, insurance-backed service rather than a purely cash-pay add-on. The specific CPT lists, units, and documentation that drive correct, compliant reimbursement are taught in Empire's course; we deliberately do not reproduce a code list here, because coding done wrong is a compliance risk, not a shortcut. Allergy fits naturally alongside the rest of the functional medicine service lines a modern practice offers.

Allergy testing & treatment guide directory

This cluster covers allergy testing and treatment end to end — the science, the testing, the conditions, the treatments, and the practice build-out. Explore the individual guides below.

How providers get trained

Licensed physicians, nurse practitioners, physician assistants, and nurses can all add allergy testing and treatment with appropriate training, the right setting, and emergency readiness. A strong program teaches more than a list of allergens — it covers testing technique and interpretation, when to refer a higher-risk patient out, immunotherapy build-up and maintenance, vial preparation, the in-office allergy lab, and the billing and coding that make the service viable. Empire's allergy curriculum is structured exactly this way and sits within the broader Academy of Anti-Aging & Functional Medicine, alongside hormone therapy, IV nutrient therapy, gut health, and weight management. To go deeper on any single topic, explore the guides in the directory above or return to the Resource Center.